Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
VFEND Plv 40 mg/ml für Susp Fl 70 ml
Drug
Vfend 40 mg/ml, Pulver zur Herstellung einer Suspension zum Einnehmen
Pilzinfektionen
08.06.0. – antifungals
HAM – Human medicine
PULS – Powder for oral suspension
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
11/25/2004
12/31/9999
Dosage strength
Vfend 40 mg/ml, Pulver zur Herstellung einer Suspension zum Einnehmen
Pilzinfektionen
01
Z – approved
Package
7680568190028
In trade from / since 11/25/2004
A/R – Authorised / referenced
70 ml
002
Z – approved
Declaration
Component
40 mg voriconazolum
542.4 mg saccharum
silica colloidalis anhydrica
titanii dioxidum
xanthani gummi
natrii citras dihydricus
acidum citricum
aromatica
2.4 mg E 211
1.08 mg natrium
silica colloidalis anhydrica
titanii dioxidum
xanthani gummi
natrii citras dihydricus
acidum citricum
aromatica
2.4 mg E 211
1.08 mg natrium
Spezialitätenliste***
SL
-
-
691.75
None
No
10%
No
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.